Moderna Vaccine 30000

Drugmaker moderna on thursday announced it had successfully enrolled 30 000 participants in a late stage study for its coronavirus vaccine marking a crucial step toward gaining fda approval for.

Moderna vaccine 30000. The results come hot on the heels of similar results from pfizer and add to growing. The moderna trial involved more than 30 000 participants in the us split into two groups with one group given two doses of the vaccine and the other group given a placebo. A vaccine against covid 19 developed by us biotech firm moderna will enter the third and final stage of its clinical trial in july with 30 000 participants the manufacturer has announced. More than 30 000 participants at 100 clinical research sites in the united states are participating in the study which launched on july 27 2020 after results from earlier stage clinical testing indicated that the vaccine candidate is well tolerated and immunogenic.

The analysis evaluated 95 confirmed covid 19 infections among the trial s 30 000 participants. A new vaccine that protects against covid 19 is nearly 95 effective early data from us company moderna shows. Moderna which developed its vaccine in collaboration with the national institute of allergy and. In a posting on clinicaltrials gov moderna said the trial is expected to begin on july 27.

It will enroll 30 000 adults at high risk of contracting the coronavirus. The world s biggest covid 19 vaccine study is now underway with the first of 30 000 planned volunteers helping to test shots created by the u s.